Novel Excipients Needed More Than Ever Before: Without an independent approval pathway for novel excipients, true pharmaceutical innovation could be stymied.
| Publicado en: | Pharmaceutical Technology Vol. 45; no. 3; pp. 24 - 28 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Mar2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=149237401&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 149237401 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15432521 4FK jtl: Pharmaceutical Technology issn: 15432521 maglogo: N pubinfo: dt: Mar2021 vid: 45 iid: 3 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 149237401 149237401 ppf: 24 ppct: 4 formats: fmt: @attributes: type: P tig: atl: Novel Excipients Needed More Than Ever Before: Without an independent approval pathway for novel excipients, true pharmaceutical innovation could be stymied. aug: au: Challener, Cynthia A. sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|